Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Early Detection of COPD Exacerbations Using Home Monitoring Device

NCT: NCT07554352 · NOT_YET_RECRUITING

NCT IDNCT07554352
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2027-05

Brief Summary

The goal of this observational study is to evaluate the safety and effectiveness of a home-monitoring device (RespirAI) in the early detection of COPD exacerbations in adults (age \>21) with physician-diagnosed COPD who are at high risk for exacerbations. The study will collect data from participants with COPD that will be analyzed using an AI-based algorithm to predict exacerbation events. The device's predictions will then be compared against clinically documented exacerbations to assess detection accuracy.

Frequently Asked Questions

What is Early Detection of COPD Exacerbations Using Home Monitoring Device?

Early Detection of COPD Exacerbations Using Home Monitoring Device is a clinical trial registered under NCT07554352. Current status: NOT_YET_RECRUITING.

What is the status of NCT07554352?

The current status of NCT07554352 (Early Detection of COPD Exacerbations Using Home Monitoring Device) is: NOT_YET_RECRUITING.

When did Early Detection of COPD Exacerbations Using Home Monitoring Device start?

Early Detection of COPD Exacerbations Using Home Monitoring Device started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.